RFK Jr. says China is 'eating our lunch' in biotech advances
Zachary Brennan / endpoints - China is "eating our lunch" on new drug approvals and clinical trial starts, HHS Secretary Robert F. Kennedy Jr. told Congress Tuesday, while praising the FDA's actions so far. "We are losing scientists, we're losing ...
AI Summary: Robert F. Kennedy Jr. publicly criticized U.S. biotech competitiveness—singling out China as gaining ground—and declined to fully endorse the new CDC vaccine director, blending industry critique with public‑health ambivalence. His comments underscore tensions between political positioning and health policy messaging while rattling stakeholders who prefer facts over theatrical proclamations.
- Kennedy defensive in hearings, balancing White House and base (4)
- Kennedy hesitates on CDC director, vaccine reports spark debate (5)
- On Pharma frontlines: Kennedy warns China is eating our lunch (3)
- All Other Stories
Kennedy defensive in hearings, balancing White House and base
Kennedy hesitates on CDC director, vaccine reports spark debate
On Pharma frontlines: Kennedy warns China is eating our lunch
All Other Stories
Baby food brand HiPP recalls jars in Austria after samples test positive for rat poison
abcnews - HiPP is recalling some baby food jars in Austria after samples tested positive for rat poison in Austria, Slovakia and the Czech Republic
AI Summary: Austrian health authorities have ordered a recall of specific HiPP baby food jars after lab tests detected contamination with a rodent poison. Retailers pulled the affected batches, parents are being urged to check product codes and discard implicated jars, and investigators are tracing how the contamination occurred while monitoring for any reported illnesses.
E-bike and scooter crashes driving more brain injuries
medicalxpress - The growing use of electric bikes and scooters has caused a surge in brain and spine injuries among urban riders and pedestrians, a new study shows. Led by NYU Langone Health researchers, the study found that these injuries now account for nearly 7% of tr…
AI Summary: A new analysis links the rise of e‑bikes and scooters to a measurable increase in traumatic brain injuries and trauma admissions, accounting for roughly 7% of related cases in the examined data. Researchers urge better helmet uptake, infrastructure changes and policy action to curb preventable head injuries before cities regret their micro‑mobility love affair.
CDC: Proportion of extensively drug-resistant Shigella isolates increasing
medicalxpress - The proportion of extensively drug-resistant (XDR) Shigella isolates in the United States increased from 2011–2015 to 2023, according to research published in the April 9 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality…
AI Summary: Federal health officials report a worrying uptick in extensively drug‑resistant Shigella strains, complicating treatment and raising the risk of harder‑to‑control outbreaks. The data underscore the need for enhanced surveillance, hygiene measures, antibiotic stewardship and rapid public‑health responses as standard antibiotics lose reliability. Try not to spread it—literally.
Eating more fruits and vegetables tied to unexpected lung cancer risk
sciencedaily - A surprising new study suggests that eating a very healthy diet—packed with fruits, vegetables, and whole grains—might be linked to a higher risk of lung cancer in younger non-smokers. Researchers found that patients under 50 diagnosed with lung cancer of…
AI Summary: A new analysis links higher fruit-and-vegetable consumption to an unexpected rise in lung cancer risk among younger non‑smokers, with investigators pointing to pesticide residues on produce as a likely culprit. Researchers urge careful interpretation—don’t ditch your salad—while calling for stricter residue limits, better monitoring, and further study to untangle diet, toxins, and cancer risk.
FDA updates mifepristone safety study status
Ella Jeffries / beckershospitalreview - The FDA updated its mifepristone guidance, detailing ongoing work on a safety study and the current status of the drug’s Risk Evaluation and Mitigation Strategy program. According to an April 8 news release, the agency said it is still collecting and eval…
AI Summary: The FDA updated the safety review status for mifepristone, yet the regulatory change hasn’t translated into widespread retail availability. Many community pharmacies are still hesitant to dispense the drug due to logistical, legal and reputational concerns, leaving access limited despite federal moves intended to broaden distribution — so yes, policy changed, but practice lagged.
'I'm not being listened to' - new health plan launched as women say they are still ignored
bbc - New plans to improve healthcare for women and girls have been set out, but will they change anything?
AI Summary: Health officials unveiled a new women's health plan, but many women say the rollout feels performative and that their concerns remain unheard. Patient advocates warn the initiative risks repeating past mistakes unless it embeds lived experience, transparent accountability and genuine co-design—otherwise it's policy theater with a glossy brochure.
Florida surgeon charged with manslaughter after removing wrong organ
Mariah Taylor / beckershospitalreview - Thomas Shaknovsky, MD, a Florida surgeon, was charged April 13 with second-degree manslaughter in connection with the death of a 70-year-old man during surgery. The Alabama man was vacationing in Florida when he experienced severe pain on his left side, T…
AI Summary: A Florida surgeon has been criminally charged with manslaughter after allegedly removing the wrong organ during an operation that resulted in a patient’s death. Prosecutors say the error was catastrophic, triggering an investigation and renewed scrutiny of surgical safety protocols, oversight practices, and how a single clinical mistake escalates into a criminal case.
CMS showcases first wave of digital health tools as questions about 'last mile' of adoption remain
fiercehealthcare - On Thursday, Trump administration officials unveiled the first wave of health tech tools as part of a push to make medical records more accessible to Medicare patients.
AI Summary: CMS showcased its first wave of vetted digital health tools via a new "app store" designed to streamline interoperability and distribute standardized applications across health systems. The platform aims to make vetted digital tools easily discoverable, but adoption hurdles, governance questions, and real‑world integration challenges mean hospitals may be cautious before swapping PDFs for plug‑and‑play magic.
Baylor Scott & White Health Plan to exit Medicaid, individual markets; cut 321 jobs
Jakob Emerson / beckershospitalreview - Baylor Scott & White Health Plan said April 14 it will exit the Texas Medicaid managed care market and discontinue its individual marketplace plans, affecting roughly 225,000 members and eliminating 321 jobs statewide, according to the Dallas Morning News…
AI Summary: Baylor Scott & White announced it will leave Medicaid individual markets, a move that will shed hundreds of jobs and reshape coverage options for affected enrollees. The decision highlights ongoing financial pressures in public‑program participation and raises practical concerns about access continuity for people reliant on those plans.
FDA to review whether to allow more access to certain peptides
medicalxpress - The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.
AI Summary: The FDA is moving toward expanding access to certain compounded peptides, opening a regulatory review that could loosen limits on how pharmacies and clinics obtain and prepare these popular therapies. The review balances potential patient demand and shortages against safety and quality-control concerns, putting compounding practices squarely under the spotlight.
New Bill Seeks to Lower Out-of-Pocket Drug Costs
Marissa Plescia / medcitynews - Rep. Greg Murphy introduced a bill that would require out-of-pocket prescription drug spending to count toward patients’ deductibles and out-of-pocket maximums regardless of where the drugs are purchased.The post New Bill Seeks to Lower Out-of-Pocket Drug…
AI Summary: Lawmakers introduced legislation to reduce out‑of‑pocket drug costs by allowing patients' direct drug purchases to count toward their insurance deductibles. The proposal aims to ease financial strain for people buying costly medications out‑of‑pocket, but would require insurers and pharmacy systems to change longstanding accounting and benefits practices.
Too young for the MMR shot, babies become 'sitting ducks' in measles outbreaks
medicalxpress - With baby Arthur too young for the measles vaccine and a sibling due in June, the Otwells grew nervous when the threat of the highly contagious virus started factoring into their grocery run.
AI Summary: Health reporting highlights that infants below the eligible age for the MMR vaccine remain highly vulnerable during measles outbreaks, effectively "sitting ducks" until immunization is possible. Public-health experts warn that gaps in community immunity and outbreak control measures disproportionately endanger these youngest children, underscoring the need for stronger herd-protection and targeted outbreak responses.
CMS proposes mandatory hospital-bundled model for joint replacements
Ella Jeffries / beckershospitalreview - CMS is proposing a mandatory, nationwide episode-based payment model for joint replacements that would hold most hospitals responsible for Medicare spending tied to a patient’s surgery and recovery. Beginning Oct. 1, 2027, the model — referred to as CJR-X…
AI Summary: CMS unveiled a plan to make hospitals participate in a mandatory bundled-payment model for joint replacement surgeries, offering a 2.4% payment increase tied to the new program. The proposal would standardize payment and care pathways nationwide, shifting financial and operational risk onto hospitals while aiming to curb costs and improve outcomes.
AbbVie sues HHS over 340B patient definition
Ella Jeffries / beckershospitalreview - AbbVie has filed a lawsuit challenging federal guidance on how “patient” is defined under the 340B program, according to an April 8 press release. The company said the current definition, based on guidance issued in 1996, allows covered entities to claim …
AI Summary: AbbVie has filed suit challenging HHS’s interpretation of the 340B program, arguing the agency’s “patient” definition and related guidance are outdated and legally flawed. The company seeks judicial clarity that could reshape who qualifies for discounted drugs and how hospitals and manufacturers navigate the program — yes, the pricing drama continues.
RFK Jr. launching health podcast to expose ‘hypocrisy’ and ‘corruption’
fiercehealthcare - Robert F. Kennedy Jr. is starting a podcast. Unveiling the show on social media, the Department of Health and Human Services (HHS) secretary framed the podcast as a response to public health problems that he said have made “many of us ... come to the conc…
AI Summary: Robert F. Kennedy Jr. is debuting a health-focused podcast promising to call out what he characterizes as hypocrisy and corruption in medicine and public health. The show aims to amplify skeptical takes on mainstream health institutions and policies, positioning itself as a combative platform for contrarian voices and investigations.
HHS updates vaccine panel requirements after judge's decision
medicalxpress - Health officials are changing the rules for who can serve on a key vaccine advisory panel after a judge ruled that many current members are unqualified.
AI Summary: Following a court decision, HHS has revised vaccine advisory committee requirements and the CDC is moving forward with changes to its vaccine advisory structure. Federal agencies are retooling membership and operating rules to restore advisory functions while navigating legal limits, aiming to keep vaccine guidance intact — whether the courtroom likes it or not.
- CDC delays vaccine-effectiveness reports; vaccine-priority lessons examined (4)
- Courts and states press legal challenge to HHS restructuring (4)
- HHS reconstitutes vaccine advisory panel under new charter and appointments (2)
- Kennedy-driven shake-up amplifies vaccine-safety focus and skepticism voices (2)
- All Other Stories
CDC delays vaccine-effectiveness reports; vaccine-priority lessons examined
Courts and states press legal challenge to HHS restructuring
HHS reconstitutes vaccine advisory panel under new charter and appointments
Kennedy-driven shake-up amplifies vaccine-safety focus and skepticism voices
All Other Stories
Can a single therapy session make a difference? Yes, with the right mindset
abcnews - Can a single therapy session make a difference
AI Summary: Experts report that a single, well‑structured therapy session can produce meaningful short‑term benefits for some patients when expectations, mindset, and therapeutic focus align. It’s not a miracle cure, but the finding nudges clinicians and policymakers toward pragmatic, low‑burden interventions that can provide rapid relief while longer‑term care is arranged.
FDA identifies eight deaths tied to Amgen's Tavneos
Max Bayer / endpoints - The FDA on Tuesday flagged more than 70 cases of severe liver injury and eight deaths associated with Amgen’s autoimmune treatment Tavneos, but the company said it previously notified the agency about the risk of ...
AI Summary: The FDA has tied eight patient deaths to Amgen’s drug Tavneos, prompting heightened regulatory review and industry concern. Reports outline safety signals and agency actions as clinicians and manufacturers reassess risk‑benefit profiles, while regulators weigh labeling, monitoring or other interventions to protect patients.
Congo says its mpox outbreak is over after 2 years and more than 2,200 suspected deaths
abcnews - Congo has declared the end of a two-year mpox outbreak, which is believed to have caused over 2,200 deaths
AI Summary: Republic of the Congo announced its prolonged mpox outbreak has ended after roughly two years and more than 2,200 suspected deaths, even as genomic surveillance uncovered co-circulating clades, including evidence of clade IIb lineage A.2.2. Health officials now face the twin tasks of documenting lessons and monitoring for lingering transmission.